![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZMYND12 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Zmynd12 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZMYND12 mRNA | CTD | PMID:36331819 | ZMYND12 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZMYND12 mRNA | CTD | PMID:22206623 | ZMYND12 | Human | 17beta-estradiol | decreases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of ZMYND12 mRNA | CTD | PMID:32145629 | ZMYND12 | Human | 17beta-estradiol | multiple interactions | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ZMYND12 mRNA | CTD | PMID:32741896 | ZMYND12 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ZMYND12 mRNA | CTD | PMID:32741896 | ZMYND12 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZMYND12 mRNA | CTD | PMID:22298810 | ZMYND12 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZMYND12 mRNA | CTD | PMID:32109520 and PMID:33387578 | ZMYND12 | Human | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | ZMYND12 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZMYND12 mRNA | CTD | PMID:28628672 | ZMYND12 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of ZMYND12 mRNA | CTD | PMID:24780913 | ZMYND12 | Human | acetamide | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of ZMYND12 mRNA | CTD | PMID:31881176 | ZMYND12 | Human | aflatoxin B1 | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of ZMYND12 mRNA | CTD | PMID:23630614 | ZMYND12 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ZMYND12 mRNA | CTD | PMID:27153756 | ZMYND12 | Human | benzo[a]pyrene | decreases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of ZMYND12 mRNA | CTD | PMID:22228805 | ZMYND12 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ZMYND12 mRNA | CTD | PMID:32234424 | ZMYND12 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ZMYND12 5' UTR | CTD | PMID:27901495 | ZMYND12 | Human | bisphenol A | decreases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZMYND12 mRNA | CTD | PMID:25181051 and PMID:32145629 | ZMYND12 | Human | bisphenol A | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZMYND12 mRNA | CTD | PMID:34947998 | ZMYND12 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZMYND12 mRNA | CTD | PMID:28628672 | ZMYND12 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ZMYND12 mRNA | CTD | PMID:38382870 | ZMYND12 | Human | calyculin a | decreases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | calyculin A results in decreased expression of ZMYND12 mRNA | CTD | PMID:25270620 | ZMYND12 | Human | carbon nanotube | decreases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | ZMYND12 | Human | carbon nanotube | increases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of ZMYND12 mRNA | CTD | PMID:25620056 | ZMYND12 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZMYND12 gene] | CTD | PMID:28238834 | ZMYND12 | Human | chloroprene | increases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | Chloroprene results in increased expression of ZMYND12 mRNA | CTD | PMID:23125180 | ZMYND12 | Human | Cuprizon | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of ZMYND12 mRNA | CTD | PMID:26577399 | ZMYND12 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZMYND12 mRNA | CTD | PMID:28628672 | ZMYND12 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of ZMYND12 mRNA | CTD | PMID:27188386 | ZMYND12 | Human | epoxiconazole | decreases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ZMYND12 mRNA | CTD | PMID:35436446 | ZMYND12 | Human | furan | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | furan results in increased expression of ZMYND12 mRNA | CTD | PMID:25539665 | ZMYND12 | Human | genistein | decreases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | Genistein results in decreased expression of ZMYND12 mRNA | CTD | PMID:32186404 | ZMYND12 | Human | glycidol | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | glycidol results in increased expression of ZMYND12 mRNA | CTD | PMID:24395379 | ZMYND12 | Human | indole-3-methanol | affects expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of ZMYND12 mRNA | CTD | PMID:21396975 | ZMYND12 | Human | indole-3-methanol | multiple interactions | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ZMYND12 mRNA | CTD | PMID:22129741 | ZMYND12 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZMYND12 mRNA | CTD | PMID:28628672 | ZMYND12 | Human | methamphetamine | decreases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Methamphetamine results in decreased expression of ZMYND12 mRNA | CTD | PMID:19564919 | ZMYND12 | Human | methoxychlor | affects methylation | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of ZMYND12 gene | CTD | PMID:35440735 | ZMYND12 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ZMYND12 mRNA | CTD | PMID:22129741 | ZMYND12 | Human | N-Nitrosopyrrolidine | decreases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in decreased expression of ZMYND12 mRNA | CTD | PMID:32234424 | ZMYND12 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of ZMYND12 mRNA | CTD | PMID:24768652 and PMID:25583101 | ZMYND12 | Human | O-methyleugenol | decreases expression | EXP | | 6480464 | methyleugenol results in decreased expression of ZMYND12 mRNA | CTD | PMID:32234424 | ZMYND12 | Human | paracetamol | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of ZMYND12 mRNA | CTD | PMID:33387578 | ZMYND12 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Zmynd12 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZMYND12 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ZMYND12 mRNA | CTD | PMID:36331819 | ZMYND12 | Human | perfluorooctanoic acid | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of ZMYND12 mRNA | CTD | PMID:28511854 | ZMYND12 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZMYND12 mRNA | CTD | PMID:19710929 | ZMYND12 | Human | pirinixic acid | increases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ZMYND12 mRNA | CTD | PMID:18301758 and PMID:20813756 | ZMYND12 | Human | pirinixic acid | multiple interactions | ISO | Zmynd12 (Mus musculus) | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of ZMYND12 mRNA | CTD | PMID:20813756 | ZMYND12 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of ZMYND12 mRNA | CTD | PMID:26079696 | ZMYND12 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of ZMYND12 mRNA | CTD | PMID:25895662 | ZMYND12 | Human | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of ZMYND12 mRNA | CTD | PMID:26833863 | ZMYND12 | Human | tamoxifen | increases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of ZMYND12 mRNA | CTD | PMID:25123088 | ZMYND12 | Human | testosterone | multiple interactions | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ZMYND12 mRNA | CTD | PMID:32741896 | ZMYND12 | Human | trichloroethene | increases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of ZMYND12 mRNA | CTD | PMID:25549359 | ZMYND12 | Human | trichloroethene | increases expression | ISO | Zmynd12 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of ZMYND12 mRNA | CTD | PMID:33387578 | ZMYND12 | Human | Triptolide | increases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | triptolide results in increased expression of ZMYND12 mRNA | CTD | PMID:32835833 | ZMYND12 | Human | triptonide | increases expression | ISO | Zmynd12 (Mus musculus) | 6480464 | triptonide results in increased expression of ZMYND12 mRNA | CTD | PMID:33045310 | |